Study may answer critics' fears about preop breast MRI

Publication
Article
Oncology NEWS InternationalOncology NEWS International Vol 17 No 2
Volume 17
Issue 2

Greater utilization of dynamic contrast-enhanced MRI at the University of California, San Diego, over a 6-year period helped improve surgery planning for tough breast cancer cases without hiking mastectomy rates

CHICAGO—Greater utilization of dynamic contrast-enhanced MRI at the University of California, San Diego, over a 6-year period helped improve surgery planning for tough breast cancer cases without hiking mastectomy rates, Christopher Comstock, MD, said in a presentation at RSNA 2007.

"Preoperative MRI has been shown in multiple studies to help change surgical management in a significant number of patients. However, some critics have raised concerns about the potential of preoperative MRI to increase mastectomy rates and cause delays in surgery, due to clinically insignificant disease detected by MRI," said Dr. Comstock, chief of breast imaging at UCSD.

Critics are less likely to cite lumpectomy's positive margin rates, which range from 30% to 40% nationwide and result in multiple surgeries to obtain clear margins, he said.

The study evaluated the effects of preoperative MRI on surgery in terms of delays and margins in patients with biopsy-proven breast cancer who underwent surgery at UCSD from 2000 to 2006. In the first 2 years of the study, only one patient had preoperative MRI. By the latter part of 2003, 40% to 50% of surgical patients were undergoing MRI.

The lumpectomy negative margin rate was higher for those who had preoperative MRI than for those who did not (80% vs 75%). "This may not seem like a big difference, but those who underwent preoperative MRI had larger or more complicated cancers or parenchymal patterns," Dr. Comstock said.

Lumpectomy negative margin rates reached 90% by 2006, a sign of better communication between radiologists and surgeons to maximize surgical outcomes and minimize delays, he said.

Despite increasing utilization of preoperative MRI, mastectomy rates remained stable throughout most of the study period. The results are partly a credit to the surgeons who used the MRI information wisely and counseled patients appropriately, Dr. Comstock said.

Furthermore, the researchers did not see a significant increase in the time to surgery for patients who underwent preoperative breast MRI, he said.

Recent Videos
Breast cancer care providers make it a goal to manage the adverse effects that patients with breast cancer experience to minimize the burden of treatment.
Social workers and case managers may have access to institutional- or hospital-level grants that can reduce financial toxicity for patients undergoing cancer therapy.
Insurance and distance to a tertiary cancer center were 2 barriers to receiving high-quality breast cancer care, according to Rachel Greenup, MD, MPH.
Antibody-drug conjugates are effective, but strategies such as better understanding the mechanisms of action may lead to enhanced care for patients with cancer. Antibody-drug conjugates are effective, but strategies such as better understanding the mechanisms of action may lead to enhanced care for patients with cancer.
ADCs demonstrate superior efficacy vs chemotherapy but maintain a similar efficacy profile that requires multidisciplinary collaboration to optimally treat.
According to Aditya Bardia, MD, MPH, FASCO, antibody-drug conjugates are slowly replacing chemotherapy as a standard treatment for breast cancer.
Administering oral SERD-based regimens may enhance patients’ quality of life when undergoing treatment for ER-positive, HER2-negative breast cancer.
Gedatolisib-based triplet regimens may be effective among patients with prior endocrine resistance or rapid progression following frontline therapy.
Leading experts in the breast cancer field highlight the use of CDK4/6 inhibitors, antibody-drug conjugates, and other treatment modalities.
Related Content